Advertisement
BAX vs LH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a StrongBuy and LH is a Buy.
BAX in upward trend: 10-day moving average crossed above 50-day moving average on October 22, 2026
The 10-day moving average for BAX crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 03, 2026. You may want to consider a long position or call options on BAX as a result. In 45 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.
The Moving Average Convergence Divergence (MACD) for BAX just turned positive on November 04, 2026. Looking at past instances where BAX's MACD turned positive, the stock continued to rise in 19 of 46 cases over the following month. The odds of a continued upward trend are 41%.
BAX moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAX advanced for three days, in 166 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
BAX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 143 of 210 cases where BAX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
Bearish Trend Analysis
The 10-day RSI Indicator for BAX moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 23 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 72%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. BAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.148) is normal, around the industry mean (4.964). P/E Ratio (-12.459) is within average values for comparable stocks, (40.591). BAX's Projected Growth (PEG Ratio) (36.677) is very high in comparison to the industry average of (4.143). Dividend Yield (0.002) settles around the average of (0.005) among similar stocks. P/S Ratio (1.057) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
LH's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for LH turned positive on October 08, 2026. Looking at past instances where LH's MACD turned positive, the stock continued to rise in 38 of 51 cases over the following month. The odds of a continued upward trend are 75%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on LH as a result. In 59 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
LH moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for LH crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +2.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where LH advanced for three days, in 195 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
The Aroon Indicator entered an Uptrend today. In 117 of 206 cases where LH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
LH broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 4 (best 1 - 100 worst), indicating outstanding price growth. LH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.454) is normal, around the industry mean (67.298). P/E Ratio (30.121) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (1.206) is also within normal values, averaging (3.473). LH has a moderately high Dividend Yield (0.008) as compared to the industry average of (0.002). P/S Ratio (1.876) is also within normal values, averaging (9.775).
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 25 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
BAX | LH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 22 | 40 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 25 | |
SMR RATING 1..100 | 94 | 65 | |
PRICE GROWTH RATING 1..100 | 39 | 4 | |
P/E GROWTH RATING 1..100 | 68 | 23 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LH's Valuation (11) in the Servicestothe Health Industry industry is significantly better than the same rating for BAX (92) in the Medical Specialties industry. This means that LH’s stock grew significantly faster than BAX’s over the last 12 months.
LH's Profit vs Risk Rating (25) in the Servicestothe Health Industry industry is significantly better than the same rating for BAX (100) in the Medical Specialties industry. This means that LH’s stock grew significantly faster than BAX’s over the last 12 months.
LH's SMR Rating (65) in the Servicestothe Health Industry industry is in the same range as BAX (94) in the Medical Specialties industry. This means that LH’s stock grew similarly to BAX’s over the last 12 months.
LH's Price Growth Rating (4) in the Servicestothe Health Industry industry is somewhat better than the same rating for BAX (39) in the Medical Specialties industry. This means that LH’s stock grew somewhat faster than BAX’s over the last 12 months.
LH's P/E Growth Rating (23) in the Servicestothe Health Industry industry is somewhat better than the same rating for BAX (68) in the Medical Specialties industry. This means that LH’s stock grew somewhat faster than BAX’s over the last 12 months.
| BAX | LH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 72% | 1 day ago 49% |
| Stochastic ODDS (%) | 1 day ago 71% | 1 day ago 58% |
| Momentum ODDS (%) | 1 day ago 53% | 7 days ago 60% |
| MACD ODDS (%) | 1 day ago 41% | 3 days ago 75% |
| TrendWeek ODDS (%) | 1 day ago 60% | 1 day ago 58% |
| TrendMonth ODDS (%) | 1 day ago 63% | 1 day ago 53% |
| Advances ODDS (%) | 1 day ago 58% | 3 days ago 58% |
| Declines ODDS (%) | 13 days ago 67% | 9 days ago 53% |
| BollingerBands ODDS (%) | 1 day ago 57% | 1 day ago 43% |
| Aroon ODDS (%) | 1 day ago 68% | 1 day ago 57% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BAX’s FA Score shows that 0 FA rating(s) are green while LH’s FA Score has 4 green FA rating(s).
- BAX’s FA Score: 0 green, 5 red.
- LH’s FA Score: 4 green, 1 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BAX’s TA Score shows that 7 TA indicator(s) are bullish while LH’s TA Score has 6 bullish TA indicator(s).
- BAX’s TA Score: 7 bullish, 3 bearish.
- LH’s TA Score: 6 bullish, 4 bearish.
Price Growth
BAX (@Pharmaceuticals: Other) experienced а +3.65% price change this week, while LH (@Medical Specialties) price change was +4.79% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.44%. For the same industry, the average monthly price growth was +4.11%, and the average quarterly price growth was +16.86%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.40%. For the same industry, the average monthly price growth was -7.16%, and the average quarterly price growth was +34.99%.
Reported Earning Dates
BAX is expected to report earnings on Feb 18, 2027.
LH is expected to report earnings on Feb 11, 2027.
Industries' Descriptions
@Pharmaceuticals: Other (+4.44% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical Specialties (-4.40% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
BAX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BAX has been loosely correlated with ICUI. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then ICUI could also see price increases.
| Ticker / NAME | Correlation To BAX | 1D Price Change % | ||
|---|---|---|---|---|
| BAX | 100% | +0.04% | ||
| ICUI - BAX | 56% Loosely correlated | +1.82% | ||
| LUNG - BAX | 53% Loosely correlated | N/A | ||
| STE - BAX | 51% Loosely correlated | +0.07% | ||
| SYK - BAX | 51% Loosely correlated | -0.44% | ||
| BDX - BAX | 49% Loosely correlated | -1.23% | ||
More | ||||
LH and
Correlation & Price change
A.I.dvisor indicates that over the last year, LH has been closely correlated with DGX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if LH jumps, then DGX could also see price increases.